FIELD: genetic engineering. SUBSTANCE: method involves construction of recombinant plasmid DNA pLPC-167G or pLPC-167F encoding zymogenic form of human C-protein. Transformants 293/pLPC-167G, or 293/pLPC-167F, or AV12/pLPC-167G, or AV12/pLPC are cultivated, and the end product is isolated and purified. EFFECT: improved method of preparing. 2 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CONSTRUCTION OF RECOMBINANT PLASMID DNA, ENCODING HUMAN ZYMOGEN C | 0 |
|
SU1739854A3 |
| METHOD OF PREPARING OF RECOMBINANT PLASMID DNA AND A METHOD OF PREPARING OF ZYMOGENIC FORM OF HUMAN PROTEIN C | 0 |
|
SU1838411A3 |
| METHOD OF PREPARING OF HUMAN RECOMBINANT ACTIVATED PROTEIN C | 0 |
|
SU1830081A3 |
| INSULIN ANALOG SHOWING CAPABILITY TO DECREASE BLOOD GLUCOSE CONTENT | 1991 |
|
RU2109749C1 |
| METHOD OF TYLOSINE PREPARING | 1987 |
|
RU2043416C1 |
| 0 |
|
SU1780542A3 | |
| GLP-I-MOLECULAR COMPLEX, PHARMACEUTICAL COMPOSITION AND METHOD OF COMPLEX PREPARING | 1995 |
|
RU2147588C1 |
| METHOD FOR CONSTRUCTING OF RECOMBINANT PLASMID DNA, ENCODING ENZYME DEACET-OXYCEPHALOSPORINE C- SYNTHETASE/DEACETYLCEPHALOSPORINE C-SYNTHETASE | 0 |
|
SU1739856A3 |
| METHOD OF EXPRESSION OF DACS/DAOCS ACTIVITY IN ESCHERICHIA COLI CELLS | 0 |
|
SU1838413A3 |
| CONSTRUCTION AND PREPARATION OF VACCINE | 1994 |
|
RU2143920C1 |
